Postoperative Adjuvant Therapy With Recombinant Interferon-Alpha Following Curative Resection of HCC

NCT00234182 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: Interferon alpha-2b

Sponsor

The University of Hong Kong